相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Corrected QT interval during treatment with methadone and buprenorphine-Relation to doses and serum concentrations.
Marianne Stallvik et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Scott R. Beach et al.
PSYCHOSOMATICS (2013)
The Influence of Antiretroviral Therapy on the QTc Interval in an African Cohort
J. Shavadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Modeling and Simulation Approach to Characterize Methadone QT Prolongation Using Pooled Data From Five Clinical Trials in MMT Patients
J. Florian et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Effectiveness of Antiretroviral Therapy in HIV-1-Infected Active Drug Users Attended in a Drug Abuse Outpatient Treatment Facility Providing a Multidisciplinary Care Strategy
Gabriel V. Sanchez et al.
CURRENT HIV RESEARCH (2012)
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
Georgie J. MacArthur et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?
Mauro Bernardi et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations
Elsayed Z. Soliman et al.
AIDS (2011)
Cardiovagal Autonomic Function in HIV-Infected Patients with Unsuppressed HIV Viremia
Dominic C. Chow et al.
HIV CLINICAL TRIALS (2011)
Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study
Elsayed Z. Soliman et al.
JOURNAL OF ELECTROCARDIOLOGY (2011)
Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol
Gro Askgaard et al.
PLOS ONE (2011)
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence
Michael Soyka et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
Paula Tuma et al.
ANTIVIRAL THERAPY (2010)
Drug- and non-drug-associated QT interval prolongation
Charlotte van Noord et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Viral Load and CD4+ Cell Count as Risk Factors for Prolonged QT Interval in HIV-Infected Subjects: A Cohort-Nested Case-Control Study in an Outpatient Population
Ashraf Y. QaQa et al.
CARDIOLOGY (2010)
Comparison of the Effects of Methadone and Heroin on Human ether-A -go-go-Related Gene Channels
Bernd J. Zuenkler et al.
CARDIOVASCULAR TOXICOLOGY (2010)
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
Frederick L. Altice et al.
LANCET (2010)
Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study
Katinka Anchersen et al.
ADDICTION (2009)
QTc Interval Screening in Methadone Treatment
Mori J. Krantz et al.
ANNALS OF INTERNAL MEDICINE (2009)
Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study
Beny Charbit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Prevalence of long QTc interval in methadone maintenance patients
Francina Fonseca et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Prevalence and Risk Factors of Prolonged QTc Interval in HIV-Infected Patients: Results of the HIV-HEART Study
Nico Reinsch et al.
HIV CLINICAL TRIALS (2009)
Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program: An 18-Month Follow-Up Study
Monica Astals et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2009)
Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports
David P. Gallagher et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
Leonardo Calza et al.
JOURNAL OF INFECTION (2008)
Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients
Pierangelo Chinello et al.
JOURNAL OF INFECTION (2007)
Drug-induced long QT and torsade de pointes: recent advances
Prince J. Kannankeril et al.
CURRENT OPINION IN CARDIOLOGY (2007)
A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients
A. J. Busti et al.
HIV MEDICINE (2006)
Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients
C Nordin et al.
JOURNAL OF ELECTROCARDIOLOGY (2006)
A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data
DM Jonker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone
M Gil et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)